Evidence-based pregnancy testing in clinical trials: Recommendations from a multistakeholder development process

PLoS ONE

Volumn 13, Issue 9, 2018, Pages

  Morse, Jessica E ^a   Calvert, Sara B ^b   Jurkowski, Claire ^c   Tassinari, Melissa ^d   Sewell, Catherine A ^d   Myers, Evan R ^e  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); EMBRYO; FALSE POSITIVE RESULT; FEMALE; FETUS; HUMAN; PREGNANCY; RISK ASSESSMENT; WORKLOAD; BLOOD; EVIDENCE BASED PRACTICE; FALSE NEGATIVE RESULT; INTERNET; PRACTICE GUIDELINE; PREGNANCY TEST; PROCEDURES; QUESTIONNAIRE; URINE;

CHORIONIC GONADOTROPIN;

CHORIONIC GONADOTROPIN; EVIDENCE-BASED PRACTICE; FALSE NEGATIVE REACTIONS; FEMALE; GUIDELINES AS TOPIC; HUMANS; INTERNET; PREGNANCY; PREGNANCY TESTS; SURVEYS AND QUESTIONNAIRES;

EID: 85053108806     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0202474     Document Type: Article

References (24)

1. Code of Federal Regulations. Clinical holds and requests for modification. 21 CFR 312.42(b)(l)(r).
2. Stanback J, Yacobson I, Harber L. Proposed clinical guidance for excluding pregnancy prior to contraceptive initiation. Contraception. 2016; https://doi.org/10.1016/j.contraception.2016.11.003 PMID: 27888046
3. Clinical Trials Transformation Initiative. Recommendations for Pregnancy Testing in Clinical Trials. https://www.ctti-clinicaltrials.org/sites/www.ctti-clinicaltrials.org/files/recommendations/pregnancytesting_recommendations_final_0.pdf (Accessed June 29 2018)
4. Lyerly A, Little M, Faden R. The second wave: Toward responsible inclusion of pregnant women in research. Int J Fem Approaches Bioeth. 2008; 1(2):5–22. PMID: 19774226
5. U.S. Food and Drug Administration. Pregnant Women: Scientific and Ethical Considerations for Inclusion in Clinical Trials Guidance for Industry. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM603873.pdf (2018, Accessed 10 July 2018)
6. Stewart J, Breslin WJ, Beyer BK, Chadwick K, De Schaepdrijver L, Desai M, et al. Birth control in clinical trials: Industry survey of current use practices, governance and monitoring. Ther Innov Regul Sci. 2016; 50(2):155–68. https://doi.org/10.1177/2168479015608415 PMID: 27042398
7. Corneli A, Hallinan Z, Hamre G, Perry B, Goldsack JC, Calvert SB, et al. The Clinical Trials Transformation Initiative: Methodology supporting the mission. Clin Trials. 2018; 15(1_suppl):13–8. https://doi.org/10.1177/1740774518755054 PMID: 29452520.
8. Cole LA, Sasaki Y, Muller CY. Normal production of human chorionic gonadotropin in menopause. N Engl J Med 356:1184–1186. https://doi.org/10.1056/NEJMc066500 PMID: 17361004.
9. Snyder JA, Haymond S, Parvin CA, Gronowski AM, Grenache DG. Diagnostic considerations in the measurement of human chorionic gonadotropin in aging women. Clin Chem. 2005; 51(10):1830–5. https://doi.org/10.1373/clinchem.2005.053595 PMID: 16099935
10. American College of Obstetricians and Gynecologists. The American College of Obstetricians and Gynecologists Practice Bulletin no. 150. Early pregnancy loss. Obstet Gynecol. 2015; 125:1258–67. PMID: 25932865
11. Wilcox AJ, Weinberg CR, O’Connor JF, Baird DD, Schlatterer JP, Canfield RE, et al. Incidence of early loss of pregnancy. N Engl J Med. 1988; 319(4):189–94. https://doi.org/10.1056/ NEJM198807283190401 PMID: 3393170
12. Lohstroh PN, Overstreet JW, Stewart DR, Nakajima ST, Cardun JR, Boyers SP, Lasley BL. Secretion and excretion of human chorionic gonadotropin during early pregnancy. Fertil Steril. 2005; 83(4):1000–11. https://doi.org/10.1016/j.fertnstert.2004.10.038 PMID: 15820813
13. Cervinski MA, Lockwood CM, Ferguson AM, Odem RR, Stenman UH, Alfthan H, et al. Qualitative point-of-care and over-the-counter urine hCG devices differentially detect the hCG variants of early pregnancy. Clin Chim Acta. 2009; 406(1–2):81–5. https://doi.org/10.1016/j.cca.2009.05.018 PMID: 19477170
14. st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin. Clin Chem. 2009; 55(8):1484–91. https://doi.org/10.1373/clinchem.2009.124578 PMID: 19541864
15. Furtado LV, Lehman CM, Thompson C, Grenache DG. Should the qualitative serum pregnancy test be considered obsolete? Am J Clin Pathol. 2012; 137(2):194–202. https://doi.org/10.1309/ AJCPH1PJSA9TWYOZ PMID: 22261443
16. Cao Z, Rej R. Are laboratories reporting serum quantitative hCG results correctly? Clin Chem. 2008; 54(4):761–4. https://doi.org/10.1373/clinchem.2007.098822 PMID: 18375490
17. Gronowski AM, Cervinski M, Stenman UH, Woodworth A, Ashby L, Scott MG. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGβ core fragment. Clin Chem. 2009; 55:1389–94. https://doi.org/10.1373/clinchem.2008.121210 PMID: 19395437
18. Cole LA. The utility of six over-the-counter (home) pregnancy tests. Clin Chem Lab Med. 2011; 49(8):1317–22. https://doi.org/10.1515/CCLM.2011.211 PMID: 21812725
19. Ochsenkuhn R, Arzberger A, von Schonfeldt V, Engel J, Thaler CJ, Noss U. Predictive value of early serum beta-hCG levels after single blastocyst transfer. Acta Obstet Gynecol. 2009; 88(12):1382–8. https://doi.org/10.3109/00016340903322743 PMID: 19878087
20. Barnhart KT, Sammel MD, Rinaudo PF, Zhou L, Hummel AC, Guo W. Symptomatic patients with an early viable intrauterine pregnancy: HCG curves redefined. Obstet Gynecol. 2004; 104(1):50–5. https://doi.org/10.1097/01.AOG.0000128174.48843.12 PMID: 15229000
21. Gronowski A.M., Fantz C.R., Parvin C.A. Use of serum FSH to identify perimenopausal women with pituitary hCG. Clin. Chem. 2008; 54:652–656. https://doi.org/10.1373/clinchem.2007.100305 PMID: 18258666.
22. US Food and Drug Administration. 510(k) clearances—overview. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/510kClearances/. Accessed 10 March 2017.
23. Gnoth C, Johnson S. Strips of Hope: Accuracy of Home Pregnancy Tests and New Developments. Geburtshilfe Frauenheilkunde. 2014; 74:661–669. https://doi.org/10.1055/s-0034-1368589 PMID: 25100881.
24. Garland SM, Ault KA, Gall SA, Paavonen J, Sings HL, Ciprero KL, Saah A, Marino D, Ryan D, Radley D, Zhou H. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/ 18 vaccine: a combined analysis of five randomized controlled trials. Obstetrics & Gynecology. 2009 Dec 1; 114(6):1179–88. PMID: 19935017.